Methodology: The study authors conducted an exhaustive search through Medline and the Cochrane Library for RCTs assessing the maintenance doses of subcutaneous tirzepatide at 5, 10, or 15 mg once-weekly, or subcutaneous semaglutide at 0.5, 1.0, or 2.0 mg once-weekly, spanning a minimum of 12 weeks
Rabinovitz H, Friedensohn A, Leibovitz A, et al
It is not licensed for human or veterinary use by the MHRA (UK), FDA (USA), or EMA (EU) and must be handled exclusively within legitimate controlled laboratory environments
Most people know it as a tanning peptide, but that undersells what it does
The first step was a survey that took four minutes to complete
Scientists first identified it because of its remarkable ability to stimulate tissue repair and wound healing